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http://dx.doi.org/10.1016/j.jmii.2013Background: The risk of healthcare workers (HCWs) acquiring tuberculosis (TB) infection is
high. We determined the prevalence of latent TB infection (LTBI) in HCWs with a high Bacille
Calmette-Gue´rin (BCG) vaccine coverage in an intermediate TB burden country by using an
interferon-gamma release assay [QuantiFERON-TB Gold (QFT-G)] and by using the tuberculin
skin test (TST). Risk factors associated with a positive test were determined.
Methods: This prospective cross-sectional study enrolled HCWs from a medical center in
Taiwan. Participants were grouped into workers without exposure (Group 1) and workers
who self-reported a history of TB exposure (Group 2). All participants completed a question-
naire to collect demographic information and risk factors for acquiring TB. The QFT-G test
and the TST were administered and risk factors for a positive test were analyzed.
Results: We recruited 193 HCWs [149 (77.2%) female workers] with a mean age of 35.6 years.
All were BCG-vaccinated. The prevalence of LTBI was 88.8% (based on the TST) and 14.5%Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, 386, Ta-Chung
com.tw (S.S.-J. Lee), yschen@vghks.gov.tw (Y.-S. Chen).
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148 W.-T. Hung et al.(based on the QFT-G test). There was no difference between HCWs with and without known
exposure to TB. Agreement between the tests was poor (i.e., the kappa value was less than
0.05). Multivariable logistic regression showed that only the QFT-G test was associated with
age (35 years or greater) (adjusted OR, 2.53; p Z 0.03).
Conclusion: By using the QFT-G test or TST, this study found a similar prevalence of LTBI in
HCWs with and without known exposure to TB. This suggests that in intermediate TB burden
countries exposure to TB may occur within the hospital and within the community. Compared
to the TST, the QFT-G test was correlated better with age, which is a known risk factor for
latent TB infection.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Tuberculosis (TB) poses a significant occupational health
problem in healthcare workers (HCWs) because of the
increased risk of exposure to TB. HCWs generally have a
higher incidence of TB than the general population. The
incidence of TB among Malaysian HCWs during the years
2003e2006 was reportedly 73.4e77.7 per 100,000 workers,
compared to 60.3e62.6 per 100,000 people in the general
population.1 In high TB burden settings such as India, HCWs
are twice more likely to develop active TB, compared to the
general population.2 A systematic review of 51 studies on the
performance of the interferon-gamma (IFN-g) release assay
(IGRA) in HCWs in cross-sectional and in serial testing studies
showed that theprevalenceand incidenceofTB infectionand
disease were high among HCWs in low income and middle
income countries; this mostly included countries with a high
burden of TB and/or human immunodeficiency virus (HIV).3
Latent TB infections comprise a significant reservoir of
future epidemics.4 Targeted treatment of latent TB infection
in high-risk groups is an important strategy in TB control.
Therefore, the screeningandtreatmentofHCWs for latentTB
infection in low TB incidence countries is crucial in an
infection control program.5 However, the implementation of
this strategy in high TB incidence countries is hindered by
uncertainty in the ability of current diagnostic tests to
accurately identify workerswhowill benefit from treatment.
Two tests are currently available for the diagnosis of
latent TB infection: the tuberculin skin test (TST) and the
IGRA test.6 The primary drawbacks of the TST are: (1) poor
specificity because of previous vaccination with the Bacille
Calmette-Gue´rin (BCG) vaccine or because of exposure to
nontuberculous mycobacterium, (2) the need for workers to
make a return visit to have the test result interpreted, (3)
the subjectivity involved in reading the test result, and (4)
the boosting phenomenon.7
The QuantiFERON-TB Gold (QTF-G, Cellestis Limited,
Melbourne, Australia) test is a whole blood IGRA that uses a
mixture of two antigens that are specific for Mycobacterium
tuberculosis and are encoded by the region of difference 1
(RD1). The antigensdearly secreted antigenic target 6
(ESAT-6) and culture filtrate protein 10 (CFP-10)dstimulate
T lymphocytes to release interferon-gamma. These new
assays have several advantages over the TST such as a
higher specificity without cross-reactivity with BCG strains
or environmental mycobacteria, logistic simplicity, and the
requirement of only one worker visit.7In 2011, Taiwan had an annual incidence of TB infection
of 54.5 per 100,000 population.8 Since 1965, the National
Immunization Program has included neonatal BCG vacci-
nation. The national coverage was 87% in 1975; 98% in 2001;
and 97% thereafter.9 Coverage reached 99.8% in 2004.10.
The aim of this study was to: (1) determine (by using the
TST and the QFT-G test) the prevalence of latent TB
infection in HCWs in a country with an intermediate TB
burden (i.e., 10e100 cases of TB per 100,000 population)
and a high BCG vaccination coverage; (2) to compare the
TST and the QFT-G test results in HCWs with and without
known exposure to patients with active TB; and (3) to
determine the risk factors for a positive test.
Methods
This prospective cross-sectional study was conducted from
2004 to 2008 in a 1408-bed medical center in southern
Taiwan. The center annually services approximately 350
patients with TB. Study participants were recruited by
posters and invited to participate by announcements in
various departments and wards within the hospital. They
were grouped into workers without a history of unprotected
exposure to TB (Group 1) and workers with a self-reported
history of unprotected exposure to TB (Group 2). The study
protocol was approved by the Institutional Review Board of
the Kaohsiung Veterans General Hospital.
All HCWs received medical evaluation and chest X-rays
to exclude active TB disease, and received further medical
evaluation if they were symptomatic (which included acid-
fast staining and mycobacterial culture of the sputum). A
questionnaire was administered to collect demographic
data and included the participants’ age, sex, occupation,
BCG vaccination status, and risk factors for TB, such as
having a past history of exposure to TB or having active TB
disease.
Blood was drawn for QFT-G testing prior to the two-step
TST.Theparticipant’sbloodsamplesweredeliveredwithin12
hours to the laboratory for analysis. The blood samples were
mixed with specific antigens (ESAT-6 and CFP-10) of Myco-
bacterium. tuberculosis and incubated for 16e24 hours.
Blood samples were also mixed with mitogen phytohemag-
glutinin (i.e., positive control) and saline (i.e., negative
control). All values were interpreted after subtracting the
value of the negative control, which was the background
level. The QFT-G test results were interpreted as: “positive”
if the IFN-g level in response to either the ESAT-6 or CFP-10
Table 1 Baseline characteristics of BCG-vaccinated
healthcare workers who were grouped by workers denying
TB exposure (Group 1) and workers with a self-reported
history of unprotected TB exposure (Group 2) to patients
with tuberculosis (n Z 193)
Characteristic Group 1
(n Z 111)
Group 2
(n Z 82)
p
Age (y), mean (SD) 36.1 (8.2) 34.8 (5.5) 0.19
Sex (female) 96 (86.5) 53 (64.6) <0.001
BCG vaccination 111 (100.0) 82 (100.0) e
Occupation
Nurse 48 (43.2) 34 (41.5) e
Doctor 14 (12.6) 13 (15.9) e
Laboratory
technician
22 (19.8) 1 (1.2) e
Administrative
staff
27 (24.3) 33 (40.2) e
Other 0 (0.0) 1 (1.2) e
Self-reported
exposure to TB
0 (0.0) 82 (100.0) e
Data are presented as n (%), unless otherwise indicated.
BCG Z Bacille Calmette-Gue´rin; HCWs Z healthcare workers;
SD Z standard deviation; TB Z tuberculosis.
Latent tuberculosis infection in healthcare workers 149was at least 0.35 IU/mL; “negative” if the IFN-g level was less
than 0.35 IU/mL and the IFN-g level in response to mitogen
(i.e., positive control) was at least 0.5 IU/mL; and “indeter-
minate” if the IFN-g levelwas less than0.35 IU/mL in response
to ESAT-6 or CFP-10 and the positive control was less than
0.5 IU/mL, or if the negative control was greater than 0.7 IU/
mL, irrespective of the IFN-g response to ESAT-6 or CFP-10.
The TST was performed by giving 2TU tuberculin RT-23
intradermally (Statens Serum Institute, Copenhagen,
Denmark) on the volar surface of the forearm. The diam-
eter of the indurated area was measured 48e72 hours later
by the intramural Mantoux method and was considered
positive when the area was 10 mm or greater. A two-step
tuberculin skin test was administered to all participants to
avoid the booster phenomenon. If the first-step TST result
was negative, the second-step TST was administered 1e3
weeks later. If either the baseline first-step TST result was
positive or the first-step TST result was negative but the
second-step TST result was positive, the participants were
evaluated for TB disease. If the first- and second-step TST
results were both negative, the person was classified as not
infected with M. tuberculosis.
Statistical analysis
Data were analyzed using Stata Statistical Software:
Release 10 (StataCorp LP, College Station, TX). The Pearson
Chi-square analysis or the Fisher’s exact test was used for
comparing categorical variables. Continuous variables were
compared by using the Student t test or the Wilcoxon rank
sum test, as appropriate. Concordance between the TST
and QFT-G test results was evaluated by the kappa coeffi-
cient (a k value greater than 0.75 indicated excellent
agreement; a k value less than 0.4, poor agreement; and a
k value between 0.4 and 0.75, fair to good agreement).11
Risk factors for QFT-G test and TST positivity were deter-
mined by using multivariable logistic regression analysis.
Age and sex were included a priori in the final model.
Results
A total of 193 HCWs were recruited into the study, mostly
women [149 (77.2%) women], with a mean age of 35.6 years
[standard deviation (SD), 7.2 years] and an age range of
21.0 years to 54.4 years. All HCWs received the BCG
vaccination either in infancy or during childhood. The oc-
cupations of the HCWs included 82 (42.5%) nurses; 60
(31.3%) administrative staff; 27 (14.0%) doctors, 23 (11.9%)
laboratory technicians, and 1 (0.5%) from another occupa-
tion. Group 1 (n Z 111) consisted of HCWs without known
exposure to TB. Group 2 (n Z 82) consisted of HCWs who
self-reported a history of unprotected exposure to patients
with active TB. There was no difference between the
baseline characteristics of the two groups, except that
there were more females in Group 1 (Table 1).
Prevalence of latent TB infection, as assessed by
the QFT-G test
The prevalence of latent TB infection in the 193 HCWs,
based on QFT-G positivity, was 14.5% [95% confidenceinterval (95% CI), 9.9-20.3]. The QFT-G response was inde-
terminate in 7.8% (95% CI, 4.4-12.5). There was no signifi-
cant difference between the prevalence of QFT-G positivity
in HCWs with (15.3%) and without (13.4%) known exposure
to patients with active TB (p Z 0.14). The prevalence of
latent TB infection was significantly higher (based on the
QFT-G test) in HCWs who were 35 years or older (22.1%)
than in workers who were younger than 35 years (9.8%;
p Z 0.02). On multivariable logistic regression analysis, an
age older than 35 years was associated with a positive QFT-
G test result [adjusted odds ratio (OR), 2.53; 95% CI, 1.07-
5.98; p Z 0.03], after adjusting for sex and history of
exposure to TB (Table 2).Prevalence of latent TB infection, as assessed by
TST
The TST was administered to 187 HCWs (three participants
each in Group 1 and Group 2 refused the TST); 179 HCWs
completed the two-step TST (Table 3). Fig. 1 shows the
distribution of the size of the TST induration in the two
HCW groups. The two-step TST was overall positive in 88.8%
(95% CI, 83.3e93.0) of the HCWs, when using the 10 mm
cut-off criterion, and positive in 66.9% (95% CI, 59.2e74.0)
of the HCWs, when using the 15-mm cut-off criterion. In
Group 1, 93 (91.2 %) participants (95% CI, 83.9e95.9) had
positive TST results when using the 10-mm cut-off value,
compared to 61 (66.3%) participants (95% CI, 55.7e75.8)
when using the 15-mm cut-off value.
In Group 2, the TST was positive in 66 (85.7%) partici-
pants (95% CI, 75.9e92.6) when using the 10-mm cut-off
value, and positive in 50 (67.6%) participants (95% CI,
55.7e78.0) when using the 15-mm cut-off value. There
were no significant differences between the two groups in
Table 2 Multivariate logistic regression analysis of the risk factors for a positive QuantiFERON-TB Gold test result or tuberculin
skin test result in BCG-vaccinated healthcare workers
QFT-G positive (n Z 178)b TST positivea (n Z 179)
Variables Adjusted ORc 95% CI p Adjusted ORc 95% CI p
Age 35 y 2.54 1.08e6.01 0.03 2.53 0.92e6.98 0.07
Sex 0.56 0.17e1.78 0.32 1.64 0.49e5.53 0.43
Exposure to TB 1.12 0.47e2.64 0.80 0.53 0.20e1.42 0.21
a A two-step TST was administered and considered positive if the induration was 10 mm.
b Fifteen patients were excluded who had indeterminate results on the QuantiFERON-TB Gold test.
c Multivariate analysis was adjusted for age, sex, and exposure to TB.
BCG Z Bacille Calmette-Gue´rin; CI Z confidence interval; OR Z odds ratio; QFT-G Z QuantiFERON-TB Gold; TB Z tuberculosis;
TST Z tuberculin skin test.
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85.7%) of positive results when using the TST at a 10-mm
cut-off value (pZ 0.25) or when using other cut-off criteria
(Table 3). On multivariable logistic regression analysis,
neither age, sex, nor a history of exposure to TB was
associated with a positive TST (Table 2).Booster effect of the two-step TST
A two-step TST increased the proportion of TST positivity
from 74.9% to 88.8% when using the cut-off criteria of
10 mm (p Z 0.001). Fig. 2 shows the booster effect of the
two-step TST when using other cut-off criteria. DifferencesTable 3 Tuberculin skin test and QuantiFERON TB-Gold
test results of BCG-vaccinated healthcare workers who are
grouped by workers without TB exposure (Group 1) and
workers with known TB exposure (Group 2) to patients with
active tuberculosis (n Z 193)
Characteristic Group 1
(n Z 111)
Group 2
(n Z 82)
p
TST indurationa
(mm)
(n Z 108) (n Z 79)
One-step 12.0
(9.0e18.0)
13.0
(10.0e18.0)
0.65
Two-step 13.0
(10.0e15.0)
15.0
(8.0e18.0)
0.15
TST positivity at
various cut-offsb
10 mm 91.2 85.7 0.25
15 mm 66.3 67.6 0.86
18 mm 39.3 51.4 0.13
20 mm 22.7 33.9 0.15
QuantiFERON-TB
GOLD testc
(n Z 111) (n Z 82)
Positive 17 (15.3) 11 (13.4) 0.14
Indeterminate (ID) 5 (4.5) 10 (12.2)
Data are presented as amedian (IQR), b%, or cn (%).
BCG Z Bacille Calmette-Gue´rin; ID Z indeterminate response;
IQRZ interquartile range; TBZ tuberculosis; TSTZ tuberculin
skin test.between TST positivity after boosting was significantly
different across all cut-offs values of the TST.
Correlation between TST and QFT-G
There was a poor correlation between the TST and QFT-G
positivity when using various TST cut-off values. The overall
agreement ranged from 24.0% to 67.7% for TST cut-offs
varying between 10 mm and 20 mm, and kappa values of
less than 0.05 (Table 4).
Discussion
In this study, the prevalence of latent TB infection among
BCG-vaccinated HCWs in Taiwan was 14.5% (95% CI,
9.9e20.3, based on the QFT-G test), and 88.8% (95% CI,
83.3e93.0, based on the two-step TST). This was higher
than the prevalence reported in low incidence countries
such as Melbourne, Australia where Vinton et al12 reported
a positive rate of 6.7% by using the QFT In-tube test in 358
healthcare staff. However, the prevalence was similar to
the prevalence reported in the general Taiwanese popula-
tion in which the TST was positive in 44.4% of 135 healthy
adults and QFT-G in 16.8% of 135 healthy adults from the
community in the Kaohsiung area and with a mean age of
48.3 years (range, 27e69 years); 95.5% of the study par-
ticipants were BCG-vaccinated.13 The prevalence rates,
based on QFT-G, did not differ between HCWs and healthy
adults, even when subgroup comparisons were performed
between people younger than 35 years (9.8% vs. 12.5%,
respectively; p Z 0.58) and people 35 years and older
(22.1% vs. 18.1%, respectively; p Z 0.48; unpublished
data).13 This suggests that HCWs in intermediate TB burden
countries face a risk of exposure to TB similar to the risk in
the community, and that appropriate personal protection
equipment and good infection control practices employed
within a hospital effectively mitigated the transmission of
TB in healthcare settings. Our infection control program for
TB is part of our hospital infection control policy in which
all patients with suspected pulmonary TB and patients who
have sputum smears positive for acid-fast bacilli are
immediately transferred to the negative pressure ward for
isolation. The treatment of patients is performed promptly.
In addition, timely automatic electronic notification of a
positive sputum smear is sent to physicians and automatic
Figure 1. The distribution of the tuberculin skin test indu-
ration measured in healthcare workers (HCWs; n Z 193) with
and without a self-reported history of exposure to patients
with active tuberculosis. TST Z tuberculin skin test.
Table 4 Correlation between the QuantiFERON-TB-Gold
test results and the one-step and two-step tuberculin skin
test results, assessed at different cut-off values in TST in-
durations in BCG-vaccinated healthcare workers in Taiwan
One step
TST cut-off
(mm)
Overall
agreement (%)
Kappa
value
95% CI
10 mm 34.7 0.02 0.05 to 0.09
15 mm 56.1 0.01 0.11 to 0.13
18 mm 65.3 0.01 0.13 to 0.15
20 mm 74.6 0.01 0.14 to 0.15
Two-step
TST cut-off
(mm)
Overall
agreement (%)
Kappa
value
95% CI
10 mm 24.0 0.00 0.05 to 0.05
15 mm 40.3 0.03 0.05 to 0.12
18 mm 56.4 0.05 0.07 to 0.17
20 mm 67.7 0.05 0.11 to 0.21
BCG Z Bacille Calmette-Gue´rin; CI Z confidence interval;
TB Z tuberculosis; TST Z tuberculin skin test.
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TB is suspected based on chest X-rays or based on histo-
pathologic results of specimen biopsies. Surveillance of
HCWs for TB is by annual chest X-rays. Contacts are
screened for symptoms and receive a chest X-ray to rule out
active disease. The TST is not administered routinely
because of high rates of BCG vaccination.
The highly discordant results between the TST and the
QFT-G test have been reported in countries in which BCG
vaccination has been widely used.5 In a study performed in
332 Japanese HCWs (95% of whom were BCG-vaccinated),
9.9% had positive QFT-G results and 93.1% had an indura-
tion diameter of 10 mm on the Mantoux test.14 It has
nevertheless been shown that in HCWs with a high rate of
BCG vaccination and discordant QFT-G and TST results, a
positive QFT-G test result was associated with the presence
of known risk factors for TB exposure, whereas a positive
TST was associated most strongly with a history of BCG
vaccination.10 Our study showed that, compared to the TST,
the QFT-G test was correlated better with age, which is a
known risk factor for TB infection.15 Our findings supported
the general consensus that the TST should not solely beFigure 2. Booster effect of the two-step tuberculin skin test,
assessed by using different cut-off values in healthcare workers
in Taiwan.relied on for diagnosing latent TB infection in populations
with a high BCG vaccination coverage.16
When using the QFT-G test and the TST, the prevalence
of latent TB infection in HCWs with and without known
exposure to patients with active TB was similar in our study.
This suggests that HCWs who did not report exposure to TB
may have been unknowingly exposed to TB either within
the hospital or in the community. It has been proposed that
repeated exposure in high TB-incidence settings may
attenuate the predictive ability of a single cross-sectional
TST or IGRA result. In general, IGRAs appear to perform
better in low TB-incidence settings.2 Studies in Austria and
Germany demonstrate IGRAs have a better predictive value
in low endemic areas than in endemic countries with a high
TB burden.17 In settings with a high TB burden, all existing
tests for latent TB infectiondincluding the TST and
IGRAsdmay have only a modest predictive value and may
not identify people who are at highest risk of progressing to
TB disease.2
Our study showed that in an intermediate TB burden
country with a high coverage of BCG vaccination, high
discordance is observed between the QFT-G and the TST,
and that a positive TST result may not identify people who
are truly infected because of cross-reactivity with the BCG
strain. Compared to the TST, the QFT-G test was correlated
better with age, which is a known risk factor for TB. How-
ever, further longitudinal studies need to be performed to
determine the predictive value for the development of
active TB disease in this setting.
The strengths of this study are that this is one of the few
studies that evaluated IGRA and TST in a head-to-head
comparison in BCG-vaccinated HCWs from an intermediate
TB burden country. This study showed that the cross-
reactivity of the BCG vaccine with the TST is a significant
problem when interpreting a positive TST result if the BCG
vaccination has previously been administered in infancy
with booster doses in childhood. This study also showed
152 W.-T. Hung et al.that the QFT-G test may provide a better estimate of the
burden of disease in HCWs in intermediate TB incidence
countries.
The limitations of this study are that there is no gold
standard for the diagnosis of latent TB infection. However,
past studies have demonstrated that the QFT-G test is
better correlated with risk factors for TB and is more spe-
cific than the TST, especially in BCG-vaccinated people.18,19
Further longitudinal studies need to be performed to
determine which test can better identify individuals with
latent TB infection who will benefit from treatment,
especially in intermediate TB incidence countries.20
In conclusion, by using the QFT-G test and the TST, this
study demonstrated a similar prevalence of latent TB
infection in HCWs with and without known exposure to
patients with TB, and demonstrated a high rate of discor-
dance between the TST and the QFT-G test in HCWs who
have received BCG vaccination. This finding suggests that in
a country with an intermediate TB burden, TB infection
may occur in the hospital and within a community. This
study also supports the general consensus that the TST
should not be solely relied on for diagnosing latent TB in
populations with a high BCG vaccination coverage and that
the QFT-G test (compared to the TST) appears to be better
correlated with age, which is a known risk factor for TB
infection. Based on the QFT-G test results, the prevalence
of latent TB infection may provide public health authorities
with a better estimate of the burden of disease among
HCWs in Taiwan, thereby to enable planning of future
policies for TB control.
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